Page last updated: 2024-08-21

1-naphthylisothiocyanate and Cirrhosis, Liver

1-naphthylisothiocyanate has been researched along with Cirrhosis, Liver in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's5 (55.56)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Dai, M; Li, S; Liu, A; Lu, Z; Luo, J; Luo, Y; Qiu, J; Yang, J; Zheng, X1
Chen, Z; Dun, Z; Fang, J; Gan, C; Luosang, T; Sang, C; Wang, B; Wang, Q; Wu, Y; Xiong, T; Zeren, D1
Liang, Q; Liu, Z; Shi, Y; Tang, N; Zhang, Y1
Joshi, N; Kopec, AK; Luyendyk, JP; Towery, K; Williams, KJ1
Joshi, N; Kopec, AK; Luyendyk, JP; Ray, JL1
Carino, A; Cipriani, S; Distrutti, E; Fiorucci, S; Masullo, D; Zampella, A1
Allen, K; Cantor, GH; Copple, BL; Guo, GL; Kassel, KM; Li, G; Luyendyk, JP1
NOIR, B; PEREZ, V; RODRIGUEZGARAY, E; ROYER, M1
Lee, G; Maher, JJ; Vierling, JM; Wang, H; Xu, J1

Other Studies

9 other study(ies) available for 1-naphthylisothiocyanate and Cirrhosis, Liver

ArticleYear
Fenofibrate reverses liver fibrosis in cholestatic mice induced by alpha-naphthylisothiocyanate.
    Die Pharmazie, 2021, 02-25, Volume: 76, Issue:2

    Topics: 1-Naphthylisothiocyanate; Actins; Animals; Apoptosis Regulatory Proteins; Chemical and Drug Induced Liver Injury; Chemokine CCL2; Cholestasis; Collagen Type I; Fenofibrate; Inflammation; Liver; Liver Cirrhosis; Male; Matrix Metalloproteinase 2; Mice; Mice, Knockout; Models, Animal; Peptide Fragments; PPAR alpha; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1

2021
Intrahepatic cholestasis induced by α-naphthylisothiocyanate can cause gut-liver axis disorders.
    Environmental toxicology and pharmacology, 2021, Volume: 86

    Topics: 1-Naphthylisothiocyanate; Animals; Bile Acids and Salts; Cholestasis, Intrahepatic; Cytokines; Feces; Intestinal Diseases; Intestine, Small; Liver; Liver Cirrhosis; Male; Mice, Inbred C57BL

2021
The role of ursodeoxycholic acid on cholestatic hepatic fibrosis in infant rats.
    Molecular medicine reports, 2018, Volume: 17, Issue:3

    Topics: 1-Naphthylisothiocyanate; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bile Acids and Salts; Bilirubin; Biomarkers; Collagen Type III; Collagen Type IV; Female; gamma-Glutamyltransferase; Gene Expression; Hyaluronic Acid; Laminin; Liver; Liver Cirrhosis; Liver Function Tests; Male; Protective Agents; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid

2018
The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 349, Issue:3

    Topics: 1-Naphthylisothiocyanate; Animals; Antifibrinolytic Agents; Bile Duct Diseases; Collagen Type I; Disease Models, Animal; Fibrin; Fibrinogen; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Plasminogen Activator Inhibitor 1; Tranexamic Acid

2014
Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease.
    Toxicology, 2016, 07-15, Volume: 365

    Topics: 1-Naphthylisothiocyanate; Animals; Chemical and Drug Induced Liver Injury; Cholestasis; Clopidogrel; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Activation; Purinergic P2Y Receptor Antagonists; Receptors, Proteinase-Activated; Serotonin; Ticlopidine; Xenobiotics

2016
Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis.
    Scientific reports, 2017, 01-24, Volume: 7

    Topics: 1-Naphthylisothiocyanate; Animals; Carbon Tetrachloride; Disease Models, Animal; Extracellular Matrix; Gene Expression Profiling; Gene Expression Regulation; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Male; Mice; Rats; Receptors, Cytoplasmic and Nuclear

2017
Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.
    The American journal of pathology, 2011, Volume: 178, Issue:3

    Topics: 1-Naphthylisothiocyanate; Afibrinogenemia; Aged; Animals; Bile Ducts; Cholestasis; Chronic Disease; Collagen; Diet; Disease Models, Animal; Early Growth Response Protein 1; Feeding Behavior; Female; Fibrin; Fibrinogen; Gene Expression Regulation; Humans; Hyperplasia; Inflammation; Liver; Liver Cirrhosis; Male; Mice; Middle Aged; Neutrophils; Xenobiotics

2011
CHRONIC INTOXICATION INDUCED BY ALPHA-NAPHTHYLISOTHIOCYANATE IN THE RAT.
    Archives of pathology, 1965, Volume: 80

    Topics: 1-Naphthylisothiocyanate; Bile; Biliary Tract; Bilirubin; Cholangitis; Chromatography; Colorimetry; Cysts; Liver Cirrhosis; Liver Cirrhosis, Biliary; Metabolism; Pathology; Pharmacology; Rats; Research; Sulfobromophthalein; Thiocyanates; Toxicology; Urine

1965
Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury.
    American journal of physiology. Gastrointestinal and liver physiology, 2004, Volume: 287, Issue:3

    Topics: 1-Naphthylisothiocyanate; Animals; Bile; Biomarkers; Chemical and Drug Induced Liver Injury; Chemokines, CXC; Cholestasis; Enzyme-Linked Immunosorbent Assay; Hydroxyproline; Leukocyte Count; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Neutrophils

2004